{
  "id": 3471423,
  "title": "Biohaven Gains As SK Biopharma Licenses Kv7 Epilepsy Platform In Global Deal",
  "url": "https://urgent.news/2026/08/26/biohaven-gains-as-sk-biopharma-licenses-kv7-epilepsy-platform-in",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-26T07:33:17.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/biohaven-gains-sk-biopharma-licenses-kv7-epilepsy-platform-global-deal"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Biohaven Ltd. (BHVN), a biopharmaceutical company, on Wednesday announced a global licensing agreement with SK Biopharmaceuticals Co., Ltd. (326030.KS).",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}